We are glad to report that in a recently published EMBO Journal...
Contact
(+34) 622 243 606
Information: info@leadartis.com
Business development : licensing@leadartis.com
QUBE Technology Park
Calle de Santiago Grisolía, 2
28760 Tres Cantos, Madrid
Latest News
|
SARS-CoV-2 Spike Trimerbody could represent a therapeutic option for COVID-19.
14-10-2021
|
"Tumor-targeted costimulatory trimerbodies for cancer Immunotherapy”- A brief discussion with Juan Perez Villar, CEO, LEADARTIS.
07-06-2021
... |
Diario ABC España y Cadena Cope: Investigadores crean un nuevo anticuerpo antitumoral más eficaz
01-06-2021
El director de la unidad de inmunoterapia del cáncer del Instituto de Investigación del Hospital... |
